References

Epidermolysis bullosa

10.1038/s41572-020-0210-0 · 2020 · External reference

Dystrophic Epidermolysis Bullosa - from biochemistry to interventions

10.1016/j.matbio.2025.02.001 · 2025 · External reference

Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa

10.1016/j.jaad.2019.11.038 · 2020 · External reference

Safety and tolerability of losartan to treat recessive dystrophic epidermolysis bullosa in children (REFLECT): an open-label, single-arm, phase 1/2 trial

10.1016/j.eclinm.2024.102900 · 2024 · External reference

Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa: results from the phase III randomized double-blind phase of the EASE study

10.1093/bjd/ljac001 · 2023 · External reference

Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa

10.1056/nejmoa2206663 · 2022 · External reference

Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa

10.1001/jama.2016.15588 · 2016 · External reference

Type VII Collagen Deficiency in the Oncogenesis of Cutaneous Squamous Cell Carcinoma in Dystrophic Epidermolysis Bullosa

10.1016/j.jid.2023.05.024 · 2023 · External reference

Stopping a runaway train: targeting fibrosis in recessive dystrophic epidermolysis bullosa

10.1093/bjd/ljae300 · 2024 · External reference

Decorin counteracts disease progression in mice with recessive dystrophic epidermolysis bullosa

10.1016/j.matbio.2018.12.001 · 2019 · External reference

Monozygotic twins discordant for recessive dystrophic epidermolysis bullosa phenotype highlight the role of TGF-β signalling in modifying disease severity

10.1093/hmg/ddu102 · 2014 · External reference

Proteoglycan form and function: A comprehensive nomenclature of proteoglycans

10.1016/j.matbio.2015.02.003 · 2015 · External reference

Targeted Disruption of Decorin Leads to Abnormal Collagen Fibril Morphology and Skin Fragility

10.1083/jcb.136.3.729 · 1997 · External reference

Congenital Stromal Dystrophy of the Cornea Caused by a Mutation in the Decorin Gene

10.1167/iovs.04-0804 · 2005 · External reference

Decorin interacting network: A comprehensive analysis of decorin-binding partners and their versatile functions

10.1016/j.matbio.2016.09.009 · 2016 · External reference

Decorin: a guardian from the matrix

10.1016/j.ajpath.2012.04.029 · 2012 · External reference

Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease

10.1038/360361a0 · 1992 · External reference

Oncosuppressive roles of decorin through regulation of multiple receptors and diverse signaling pathways

10.1152/ajpcell.00016.2022 · 2022 · External reference

Systemically Administered, Target-Specific, Multi-Functional Therapeutic Recombinant Proteins in Regenerative Medicine

10.3390/nano10020226 · 2020 · External reference

Negative regulation of transforming growth factor-beta by the proteoglycan decorin

10.1038/346281a0 · 1990 · External reference

Absence of Decorin Adversely Influences Tubulointerstitial Fibrosis of the Obstructed Kidney by Enhanced Apoptosis and Increased Inflammatory Reaction

10.1016/s0002-9440(10)64937-1 · 2002 · External reference

Regulation of Fibrillin-1 by Biglycan and Decorin Is Important for Tissue Preservation in the Kidney During Pressure-Induced Injury

10.1016/s0002-9440(10)63305-6 · 2004 · External reference

Regulation of the Bioavailability of TGF-β and TGF-β-Related Proteins

10.1101/cshperspect.a021907 · 2016 · External reference

Exposed CendR Domain in Homing Peptide Yields Skin-Targeted Therapeutic in Epidermolysis Bullosa

10.1016/j.ymthe.2020.05.017 · 2020 · External reference

Age-dependent alterations of decorin glycosaminoglycans in human skin

10.1038/srep02422 · 2013 · External reference

The glycosaminoglycan chain of decorin plays an important role in collagen fibril formation at the early stages of fibrillogenesis

10.1111/j.1742-4658.2007.05951.x · 2007 · External reference

Decorin: A Growth Factor Antagonist for Tumor Growth Inhibition

10.1155/2015/654765 · 2015 · External reference

Decorin core protein secretion is regulated by N-linked oligosaccharide and glycosaminoglycan additions

10.1074/jbc.m511531200 · 2005 · External reference

Recombinant decorin glycoforms. Purification and structure

10.1074/jbc.271.32.19578 · 1996 · External reference

Unresolved reference

2022 · External reference

Systemic Collagen VII Replacement Therapy for Advanced Recessive Dystrophic Epidermolysis Bullosa

10.1016/j.jid.2021.09.008 · 2022 · External reference

Decorin Antagonizes Met Receptor Activity and Down-regulates β-Catenin and Myc Levels

10.1074/jbc.m110.172841 · 2010 · External reference

Pro-inflammatory immunity supports fibrosis advancement in epidermolysis bullosa: intervention with Ang-(1-7)

10.15252/emmm.202114392 · 2021 · External reference

Ex Vivo Transepithelial Collagen Cross-linking in Porcine and Human Corneas Using Human Decorin Core Protein

10.3928/1081597x-20160428-08 · 2016 · External reference

Chondroitin 4-sulfate covalently cross-links the chains of the human blood protein pre-alpha-inhibitor

10.1016/s0021-9258(17)35235-3 · 1991 · External reference

Crystal structure of the dimeric protein core of decorin, the archetypal small leucine-rich repeat proteoglycan

10.1073/pnas.0402976101 · 2004 · External reference

The concave face of decorin mediates reversible dimerization and collagen binding

10.1074/jbc.m113.504530 · 2013 · External reference

Differential interactions of decorin and decorin mutants with type I and type VI collagens

10.1111/j.1432-1033.2004.04273.x · 2004 · External reference

Decorin the antifibrotic proteoglycan and its progression in therapy

10.1152/ajpcell.01075.2024 · 2025 · External reference

Pharmacokinetics and disposition characteristics of recombinant decorin after intravenous injection into mice

10.1016/s0304-4165(98)00163-9 · 1999 · External reference

Target-seeking antifibrotic compound enhances wound healing and suppresses scar formation in mice

10.1073/pnas.1016233107 · 2010 · External reference

A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy

10.1172/jci34292 · 2008 · External reference

Fibroblast-Derived MMP-14 Regulates Collagen Homeostasis in Adult Skin

10.1016/j.jid.2016.03.036 · 2016 · External reference

Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms

10.15252/emmm.201505061 · 2015 · External reference

Histone deacetylase inhibition mitigates fibrosis-driven disease progression in recessive dystrophic epidermolysis bullosa

10.1093/bjd/ljae225 · 2024 · External reference

Lung collagen cross-links in rats with experimentally induced pulmonary fibrosis

10.1016/0925-4439(96)00019-1 · 1996 · External reference

The type of collagen cross-link determines the reversibility of experimental skin fibrosis

10.1016/j.bbadis.2005.02.007 · 2005 · External reference

Dipeptidyl Peptidase-4-Mediated Fibronectin Processing Evokes a Profibrotic Extracellular Matrix

10.1016/j.jid.2024.03.020 · 2024 · External reference

Pro-Inflammatory Chemokines and Cytokines Dominate the Blister Fluid Molecular Signature in Patients with Epidermolysis Bullosa and Affect Leukocyte and Stem Cell Migration

10.1016/j.jid.2017.07.002 · 2017 · External reference

Knockout of IL-1R1 Reduced Inflammation and Improved Survival in a Mouse Model of Recessive Dystrophic Epidermolysis Bullosa

10.1016/j.jid.2025.01.010 · 2025 · External reference

Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21

10.1126/scisignal.2001868 · 2011 · External reference

Communications via the Small Leucine-rich Proteoglycans: Molecular Specificity in Inflammation and Autoimmune Diseases

10.1369/0022155420930303 · 2020 · External reference

Fibrillin-1 regulates the bioavailability of TGFβ1

10.1083/jcb.200608167 · 2007 · External reference

Diversity of Mechanisms Underlying Latent TGF-β Activation in Recessive Dystrophic Epidermolysis Bullosa

10.1016/j.jid.2020.10.024 · 2021 · External reference

Decorin is a biological ligand for the epidermal growth factor receptor

10.1074/jbc.274.8.4489 · 1999 · External reference

Decorin is a novel antagonistic ligand of the Met receptor

10.1083/jcb.200901129 · 2009 · External reference

Decorin suppresses tumor lymphangiogenesis: A mechanism to curtail cancer progression

10.1073/pnas.2317760121 · 2024 · External reference

Synergetic roles of TGF-β signaling in tissue engineering

10.1016/j.cyto.2018.12.010 · 2019 · External reference

Decorin core protein fragment Leu155-Val260 interacts with TGF-beta but does not compete for decorin binding to type I collagen

10.1006/abbi.1998.0720 · 1998 · External reference

Alpha-smooth muscle actin expression upregulates fibroblast contractile activity

10.1091/mbc.12.9.2730 · 2001 · External reference

The extracellular matrix and transforming growth factor-β1: Tale of a strained relationship

10.1016/j.matbio.2015.05.006 · 2015 · External reference

The regulation of tenascin expression by tissue microenvironments

10.1016/j.bbamcr.2008.12.012 · 2009 · External reference

Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix

10.1016/s0021-9258(17)35666-1 · 1986 · External reference

Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa

10.1007/s40257-025-00942-y · 2025 · External reference

Glycosaminoglycan Modification of Decorin Depends on MMP14 Activity and Regulates Collagen Assembly

10.3390/cells9122646 · 2020 · External reference

Ageing-associated endothelial decorin induction and the impact of non-glycanated decorin on cardiac inflammation

10.1093/cvr/cvaf128 · 2025 · External reference

Non-glycanated ΔDCN isoform in muscle invasive bladder cancer mediates cancer stemness and gemcitabine resistance

10.1007/s13402-024-00998-8 · 2024 · External reference

Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation

10.1074/jbc.m602853200 · 2006 · External reference

Decorin Protein Core Affects the Global Gene Expression Profile of the Tumor Microenvironment in a Triple-Negative Orthotopic Breast Carcinoma Xenograft Model

10.1371/journal.pone.0045559 · 2012 · External reference

Decorin suppresses neurocan, brevican, phosphacan and NG2 expression and promotes axon growth across adult rat spinal cord injuries

10.1111/j.1460-9568.2004.03184.x · 2004 · External reference

Absence of the dermatan sulfate chain of decorin does not affect mouse development

10.1186/s12952-017-0074-3 · 2017 · External reference

Injury-Driven Stiffening of the Dermis Expedites Skin Carcinoma Progression

10.1158/0008-5472.can-15-1348 · 2016 · External reference

Interleukin 4 and prolonged hypoxia induce a higher gene expression of lysyl hydroxylase 2 and an altered cross-link pattern: important pathogenetic steps in early and late stage of systemic scleroderma?

10.1016/j.matbio.2005.07.002 · 2005 · External reference